New evidence for associations between vitamin D receptor polymorphism and obesity: case-control and family-based studies
Journal of Human Genetics (2019) doi:10.1038/s10038-019-0702-5
Songcheng Yu, Xing Li, Fei Yu, Zhenxing Mao, Yan Wang, Yuan Xue, Hualei Sun, Yue Ba, Chongjian Wang & Wenjie Li
The risk of 44 diseases at least double with poor Vitamin D Receptor as of Oct 2019
Vitamin D Receptor Activation can be increased by any of: Resveratrol, Omega-3, Magnesium, Zinc, non-daily Vitamin D dosing, curcumin, intense exercise, etc
Note: The founder of VitaminDWiki uses 10 of the 12 known VDR activators
- Large weight loss 32X more likely to be achieved if weight gain was due to Vitamin D Receptor – Jan 2020
- Obesity 2X higher risk if a poor Vitamin D Receptor (13th study) – Dec 2019
- Obesity 1.5 X more likely if poor Vitamin D Receptor – meta-analysis Nov 2019
- Obesity associated with poor Vitamin D genes (VDR in this study) – Jan 2018
- Skin fold thickness but not BMI associated with poor Vitamin D Receptor in Han Chinese – April 2018
- Resveratrol improves health (Vitamin D receptor, etc.)
- Obesity might be related to Vitamin D genes – July 2018
- Obesity 1.5 X more likely if poor Vitamin D receptor – Dec 2017
- Obesity in 700 young adults associated with a poor Vitamin D Receptor – Jan 2018
- Obese are 30 percent more likely to have poor Vitamin D Receptor – Aug 2017
- Vitamin D restricted in getting to cells by genes, obesity, etc – Jan 2017
- Vitamin D Receptor and Obesity – several studies
- Vitamin D activates the hypothalamus (in rodents) to reduce weight and diabetes– May 2016
- Obesity strongly associated with vitamin D receptor in Saudia Arabia – July 2014
Download the PDF from Sci-Hub via VitaminDWiki
Siblings in the same family are obese if poor VDR
Association between vitamin D receptor (VDR) genetic polymorphism and obesity was observed in several case-control studies. This study hypothesized that these associations could be verified in family-based study. We aimed at investigating the associations between VDR SNPs and obesity (BMI ≥ 28 kg/m2) by case-control study with 688 subjects and family-based study with 419 pedigrees. The results of case-control study suggested that rs3847987 (AC vs CC, Adjusted OR: 1.938, 95% CI: 1.359–2.763, P = 0.000405) was associated with obesity. Allele C of rs3847987 was risk factors for obesity (P = 0.006). Furthermore, association of rs3847987 with BMI was verified in family-based study (Z = 2.077, P = 0.037811). In addition, sibling with AC genotype of rs3847987 had significant higher BMI than CC genotype in the same family (P = 0.03). Therefore, it could be concluded that VDR genetic polymorphism (rs3847987) may be associated with obesity.
- Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. J Am Med Assoc. 2016;315:2284–91.
- Pereira-Santos M, Costa PRF, Assis AMO, Santos CAST, Santos DB. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev. 2015;16:341–9.
- Martini LA, Wood RJ. Vitamin D status and the metabolic syndrome. Nutr Rev. 2006;64:479–86.
- Al-Daghri NM, Guerini FR, Al-Attas OS, Alokail MS, Alkharfy KM, Draz HM, et al. Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PloS One. 2014;9:e102141. https://doi.org/10.1371/journal.pone.0102141.
- Fan HR, Lin LQ, Ma H, Li Y, Sun CH. Association between vitamin D receptor gene polymorphism (TaqI) and obesity in Chinese population. J Genet. 2015;94:473–8.
- Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg. 2010;126:2234–42.
- Sedgwick P. Case-control studies: advantages and disadvantages. Br Med J. 2013;348:f7707. https://doi.org/10.1136/bmj.f7707.
- Evangelou E, Trikalinos TA, Salanti G, Ioannidis JPA. Family-based versus unrelated case-control designs for genetic associations. Plos Genet. 2006;2:1147–55.
- Zhou BF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases-report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15:245–52.
- Liu X, Mao Z, Li Y, Wu W, Zhang X, Huo W, et al. The Henan Rural Cohort: a prospective study of chronic non-communicable diseases. Int J Epidemiol. 2019;26:dyz039 https://doi.org/10.1093/ije/dyz039
- Serrano D, Gnagnarella P, Raimondi S, Gandini S. Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms. Eur J Cancer Prev. 2016;25:85–96.
- dos Reis GVOP, Gontijo NA, Rodrigues KF, Alves MT, Ferreira CN, Gomes KB. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: a systematic review. J Obstet Gynaecol Res. 2017;43:436–46.
- Koletsi D, Pandis N. Conditional logistic regression. Am J Orthod Dentofac. 2017;151:1191–2.
- Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations (Reprinted from European Journal of Human Genetics, Vol 9 pgs 301–306, 2001). Eur J Hum Genet. 2017;25:S59–S62.
- Yang M, Liu R, Li X, Liao J, Pu Y, Pan E, et al. Epigenetic repression of miR-218 promotes esophageal carcinogenesis by targeting ROBO1. Int J Mol Sci 2015;16:27781–95.
- You J, Zhang Y, Li Y, Fang N, Liu B, Zu L, et al. MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer. Am J Cancer Res. 2015;5:2730–44.
- Budhathoki S, Yamaji T, Iwasaki M, Sawada N, Shimazu T, Sasazuki S, et al. Vitamin D receptor gene polymorphism and the risk of colorectal cancer: a nested case-control study. PloS One 2016;11:e0164648.
- Ramos-Lopez E, Jansen T, Ivaskevicius V, Kahles H, Klepzig C, Oldenburg J., et al. Protection from type 1 diabetes by vitamin D receptor haplotypes. In: Immunol diabetes IV: progress in our understanding. Ann. N.Y. Acad. Sci. 2006;1079:327–34.
- Mutt SJ, Hypponen E, Saarnio J, Jarvelin MR, Herzig KH. Vitamin D and adipose tissue-more than storage. Front Physiol. 2014;5:228.